| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Einfügen in | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (groß) | News + Adhoc | Bilanz/GuV | Termine | Zertifikate | Depot |
| Times + Sales | Analysechart (Java) | Analysen | Profil | Optionsscheine | Watchlist | |
| Börsenplätze | Chartvergleich | Research Statis. | Insidertrades | Knock-outs | myfinanzen | |
| Orderbuch | Stuttgart Realtime | RSS Feed | Analyse | im Forum | Fonds | |
| Historisch | IR-Daten | |||||
Analysen zur Alnylam Pharmaceuticals Inc.
| 03.03.2008 | Alnylam Pharmaceuticals Downgrade | Needham & Company, LLC | |
| 20.02.2008 | Alnylam Pharmaceuticals Basisinvestment | Biotech-Report | |
| 24.10.2007 | Alnylam Pharmaceuticals neues Kursziel | Rodman & Renshaw | |
| 10.10.2007 | Alnylam Pharmaceuticals Downgrade | Piper Jaffray & Co. | |
| 14.08.2007 | Alnylam Pharmaceuticals Downgrade | Needham & Company, LLC | |
| 10.07.2007 | Alnylam Pharmaceuticals neues Kursziel | Rodman & Renshaw | |
| 10.07.2007 | Alnylam Pharmaceuticals neues Kursziel | Caris & Company | |
| 12.05.2006 | Update Alnylam Pharmaceuticals Inc.: Above Average | Caris & Company | |
| 14.02.2006 | Update Alnylam Pharmaceuticals Inc.: Buy | Needham & Co | |
| 14.02.2006 | Update Alnylam Pharmaceuticals Inc.: Buy | Needham & Co | |
| 16.12.2005 | Update Alnylam Pharmaceuticals Inc.: Buy | Banc of America Sec. | |
| 02.02.2005 | Update Alnylam Pharmaceuticals Inc.: Buy | Banc of America Sec. |













